- Home
- ELVN vs OLPX Comparison
ELVN vs OLPX Comparison
Compare ELVN & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- OLPX
- Stock Information
- Founded
- ELVN 2016
- OLPX 2014
- Country
- ELVN United States
- OLPX United States
- Employees
- ELVN N/A
- OLPX N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- OLPX Package Goods/Cosmetics
- Sector
- ELVN Health Care
- OLPX Consumer Discretionary
- Exchange
- ELVN Nasdaq
- OLPX Nasdaq
- Market Cap
- ELVN 927.8M
- OLPX 844.1M
- IPO Year
- ELVN 2020
- OLPX 2021
- Fundamental
- Price
- ELVN $20.73
- OLPX $1.57
- Analyst Decision
- ELVN Strong Buy
- OLPX Hold
- Analyst Count
- ELVN 5
- OLPX 4
- Target Price
- ELVN $41.20
- OLPX $1.85
- AVG Volume (30 Days)
- ELVN 734.1K
- OLPX 1.2M
- Earning Date
- ELVN 08-12-2025
- OLPX 08-05-2025
- Dividend Yield
- ELVN N/A
- OLPX N/A
- EPS Growth
- ELVN N/A
- OLPX N/A
- EPS
- ELVN N/A
- OLPX 0.02
- Revenue
- ELVN N/A
- OLPX $420,742,000.00
- Revenue This Year
- ELVN N/A
- OLPX $1.32
- Revenue Next Year
- ELVN N/A
- OLPX $3.12
- P/E Ratio
- ELVN N/A
- OLPX $85.57
- Revenue Growth
- ELVN N/A
- OLPX N/A
- 52 Week Low
- ELVN $13.30
- OLPX $1.01
- 52 Week High
- ELVN $30.03
- OLPX $2.77
- Technical
- Relative Strength Index (RSI)
- ELVN 52.36
- OLPX 65.15
- Support Level
- ELVN $19.22
- OLPX $1.34
- Resistance Level
- ELVN $21.90
- OLPX $1.60
- Average True Range (ATR)
- ELVN 1.46
- OLPX 0.11
- MACD
- ELVN -0.19
- OLPX 0.01
- Stochastic Oscillator
- ELVN 40.50
- OLPX 100.00
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.